206-838-5110 ext. 102 general@etubics.com

Etubics Adds Caskey, Paessler, Zeldis to Leadership Boards

SEATTLE – (July 20, 2015) – Etubics Corporation, a privately-held, clinical stage biotechnology company developing an immunotherapy vaccine platform, has added Dr. Thomas Caskey to its Board of Directors and Drs. / Jerome Zeldis, Slobodan Paessler to its...

Gerald L. Messerschmidt Joins Etubics as Chief Medical Officer

SEATTLE – (July 9, 2015) – Etubics Corporation, a privately-held, clinical stage biotechnology company developing an immunotherapy vaccine platform, announced today that it has retained Gerald L. Messerschmidt, MD, FACP as Chief Medical Officer. The company is...